Atopic Dermatitis Clinical Trials

What Is Atopic Dermatitis?

Atopic dermatitis, often called eczema, is a chronic inflammatory skin condition that causes dry, itchy, and inflamed patches of skin. It develops when the skin barrier weakens and the immune system overreacts to everyday triggers like allergens, irritants, or stress. Atopic dermatitis commonly appears on the hands, face, neck, and the creases of the elbows and knees, though it can show up almost anywhere on the body. Flares often bring intense itching, redness, and cracked or oozing skin, and repeated scratching can lead to thickened, discolored patches over time. The condition tends to run in cycles, easing for weeks or months before flaring again, and it frequently overlaps with other allergic conditions like asthma or hay fever. While there is currently no cure, Atopic Dermatitis clinical trials continue to explore new ways to calm flares, extend remission, and give patients real relief.

For many people living with moderate to severe symptoms, Eczema clinical trials offer a path to treatments that go beyond standard creams and medications.

What is Atopic Dermatitis
Atopic Dermatitis Clinical Trials Flyer

STUDY

Finding a Potential New Treatment for Moderate-to-Severe Atopic Dermatitis

This Phase 3 clinical research study is evaluating an investigational treatment in participants aged 12 years and older with moderate-to-severe atopic dermatitis. The randomized study compares the investigational treatment with placebo. Researchers will evaluate changes in symptoms and disease severity while monitoring safety and tolerability. The main study assessment takes place at Week 24.

Participation in Atopic Dermatitis research study in Arizona may provide eligible individuals with access to an investigational treatment not yet approved for routine use, along with regular study-related assessments.

Age
12 Years and older

Location:
Arizona

Status:
Recruiting

Condition
Moderate-to-Severe Atopic Dermatitis

What to Expect in an Atopic Dermatitis Clinical Trial

What to Expect-in an Atopic Dermatitis Clinical Trial

In Atopic Dermatitis clinical trials, participants can expect a structured and closely supervised research process from start to finish. After an initial screening to confirm eligibility, participants are randomly assigned to receive either the study drug or a placebo, and neither the participant nor the study team knows which one during the blinded portion of the trial. Regular clinic visits are scheduled throughout the study for skin assessments, lab work, and check-ins on how symptoms are responding.

Participants are asked to track their itch levels, flare patterns, and any changes they notice between visits. An experienced research team monitors safety closely at every step, and this Eczema clinical study in Arizona gives participants direct access to that level of ongoing care. By taking part, participants help researchers better understand how new treatments perform in real-world settings, paving the way for improved care for people living with atopic dermatitis.

Frequently Asked
Questions

  • The study is a Phase 3 clinical trial evaluating rezpegaldesleukin as a potential Atopic Dermatitis treatment option for people ages 12 and older with moderate to severe symptoms. The study compares the study drug against a placebo to measure safety and effectiveness over time.

  • Eligibility generally includes people ages 12 and older with a confirmed diagnosis of moderate to severe atopic dermatitis, along with a certain level of skin involvement. A member of the study team reviews full eligibility criteria during screening.

  • This study is currently recruiting participants at sites across Arizona. Reach out to the study team to check nearby locations, review eligibility, and learn what participation involves before enrolling.